Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Guillain-Barré syndrome.

Yuki N, Hartung HP.

N Engl J Med. 2012 Jun 14;366(24):2294-304. doi: 10.1056/NEJMra1114525. Review. No abstract available. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

PMID:
22694000
2.

Nodal proteins are target antigens in Guillain-Barré syndrome.

Devaux JJ, Odaka M, Yuki N.

J Peripher Nerv Syst. 2012 Mar;17(1):62-71. doi: 10.1111/j.1529-8027.2012.00372.x.

PMID:
22462667
3.

CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy.

Schneider-Hohendorf T, Schwab N, Uçeyler N, Göbel K, Sommer C, Wiendl H.

Neurology. 2012 Feb 7;78(6):402-8. doi: 10.1212/WNL.0b013e318245d250. Epub 2012 Jan 11.

PMID:
22238416
4.

Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion.

Reimer MM, McQueen J, Searcy L, Scullion G, Zonta B, Desmazieres A, Holland PR, Smith J, Gliddon C, Wood ER, Herzyk P, Brophy PJ, McCulloch J, Horsburgh K.

J Neurosci. 2011 Dec 7;31(49):18185-94. doi: 10.1523/JNEUROSCI.4936-11.2011.

5.

Neurofascin as target of autoantibodies in Guillain-Barre syndrome.

Prüss H, Schwab JM, Derst C, Görtzen A, Veh RW.

Brain. 2011 May;134(Pt 5):e173; author reply e174. doi: 10.1093/brain/awq372. Epub 2011 Jan 27. No abstract available.

PMID:
21278083
6.

Pathogenesis and treatment of immune-mediated neuropathies.

Lehmann HC, Meyer Zu Horste G, Kieseier BC, Hartung HP.

Ther Adv Neurol Disord. 2009 Jul;2(4):261-81. doi: 10.1177/1756285609104792.

7.

What is IgG4? A review of the biology of a unique immunoglobulin subtype.

Nirula A, Glaser SM, Kalled SL, Taylor FR.

Curr Opin Rheumatol. 2011 Jan;23(1):119-24. doi: 10.1097/BOR.0b013e3283412fd4. Review. Erratum in: Curr Opin Rheumatol. 2011 Mar;23(2):227. Taylora, Frederick R [corrected to Taylor, Frederick R].

PMID:
21124094
8.

A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier.

Feinberg K, Eshed-Eisenbach Y, Frechter S, Amor V, Salomon D, Sabanay H, Dupree JL, Grumet M, Brophy PJ, Shrager P, Peles E.

Neuron. 2010 Feb 25;65(4):490-502. doi: 10.1016/j.neuron.2010.02.004.

9.

Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.

Kaida K, Kusunoki S.

J Neuroimmunol. 2010 Jun;223(1-2):5-12. doi: 10.1016/j.jneuroim.2010.02.001. Epub 2010 Feb 20. Review.

PMID:
20172612
10.

Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.

Lonigro A, Devaux JJ.

Brain. 2009 Jan;132(Pt 1):260-73. doi: 10.1093/brain/awn281. Epub 2008 Oct 25.

PMID:
18953054
11.

Molecular mechanisms of node of Ranvier formation.

Susuki K, Rasband MN.

Curr Opin Cell Biol. 2008 Dec;20(6):616-23. doi: 10.1016/j.ceb.2008.09.007. Epub 2008 Nov 1. Review.

12.

Differential expression and functions of neuronal and glial neurofascin isoforms and splice variants during PNS development.

Basak S, Raju K, Babiarz J, Kane-Goldsmith N, Koticha D, Grumet M.

Dev Biol. 2007 Nov 15;311(2):408-22. Epub 2007 Aug 31.

13.

Neurofascin as a novel target for autoantibody-mediated axonal injury.

Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C.

J Exp Med. 2007 Oct 1;204(10):2363-72. Epub 2007 Sep 10.

14.
15.

Post-translational modifications in the context of therapeutic proteins.

Walsh G, Jefferis R.

Nat Biotechnol. 2006 Oct;24(10):1241-52. Review.

PMID:
17033665
16.

Neurofascins are required to establish axonal domains for saltatory conduction.

Sherman DL, Tait S, Melrose S, Johnson R, Zonta B, Court FA, Macklin WB, Meek S, Smith AJ, Cottrell DF, Brophy PJ.

Neuron. 2005 Dec 8;48(5):737-42.

17.

Guillain-Barré syndrome.

Hughes RA, Cornblath DR.

Lancet. 2005 Nov 5;366(9497):1653-66. Review.

PMID:
16271648
18.

Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier.

Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR Jr, Peles E.

Neuron. 2005 Jul 21;47(2):215-29.

19.

Peripheral neuropathies and anti-glycolipid antibodies.

Willison HJ, Yuki N.

Brain. 2002 Dec;125(Pt 12):2591-625. Review.

PMID:
12429589
20.

Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction.

Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, Denisenko-Nehrbass N, Guennoc AM, Girault JA, Brophy PJ, Lubetzki C.

Curr Biol. 2002 Feb 5;12(3):217-20.

Supplemental Content

Support Center